📅 19th - 20th June 2025 📍 Heathrow, London

Gary Middleton

University of Birmingham

Gary Middleton is an honorary medical oncologist at University Hospital Birmingham. He is Chair of the Experimental Cancer Medicine Centres Network in the UK and has been CI of 8 investigator initiated clinical trials including the flagship National Lung Matrix Trial. His lab interests include myeloid-derived suppressor cells, tumour specific MHC-II expression, B cells in lung cancer particularly Bregs and their association with ICB toxicity and targeting SOX2 and replication stress in lung cancer. He is Translational Lead on the DETERMINE trial and CI on KETO-LUNG.

The conference has been instigated and organised by LCNUK. Sponsors have contributed funding towards this event in return for exhibition space. They have had no input into the agenda or the selection of speakers with the exception of any sponsored symposia which are clearly indicated.

📅 19th - 20th June 2025 📍 Heathrow, London

Gary Middleton

The conference has been instigated and organised by LCNUK. Sponsors have contributed funding towards this event in return for exhibition space. They have had no input into the agenda or the selection of speakers with the exception of any sponsored symposia which are clearly indicated.

Phone

CORRESPONDENCE ADDRESS

More information

📅 19th - 20th June 2025 📍 Heathrow, London

Gary Middleton

The conference has been instigated and organised by LCNUK. Sponsors have contributed funding towards this event in return for exhibition space. They have had no input into the agenda or the selection of speakers with the exception of any sponsored symposia which are clearly indicated.

Join Lung Cancer Nursing UK

Annual Conference

Phone

CORRESPONDENCE ADDRESS

More information